Aug
13
Sat
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
Aug 13 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

Aug
14
Sun
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
Aug 14 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

Aug
15
Mon
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
Aug 15 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

Aug
16
Tue
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
Aug 16 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

PHIND Seminar: Opportunistic Disease Prediction using Already-Acquired Medical Imaging and Deep Learning @ Hybrid Event: Li Ka Shing Center, LK120 & Zoom
Aug 16 @ 11:00 am – 12:00 pm
PHIND Seminar: Opportunistic Disease Prediction using Already-Acquired Medical Imaging and Deep Learning @ Hybrid Event: Li Ka Shing Center, LK120 & Zoom

PHIND Seminar Series: Opportunistic Disease Prediction using Already-Acquired Medical Imaging and Deep Learning

11:00am – 12:00pm Seminar & Discussion
RSVP Here

Location: LKSC, LK120 &Zoom
Zoom Details
Webinar URL: https://stanford.zoom.us/s/96233225915
Dial: US: +1 650 724 9799  or +1 833 302 1536 (Toll Free)
Webinar ID: 962 3322 5915
Passcode: 718123

 

Akshay Chaudhari, PhD
Assistant Professor of Radiology and, by courtesy, of Biomedical Data Science
Stanford University

 

Abstract
Over 88 million computed tomography (CT) scans are performed annually in the US, with abdominal CT accounting for ~20 million. While these scans answer specific clinical questions, a majority of the information in the rich 3D scans unrelated to the referral question is not evaluated. In this work, we will demonstrate how extracting additional biological insights beyond those required to answer the original clinical question can be used for predicting the onset of future disorders. We will demonstrate how we can analyze CT images using deep learning tools to opportunistically predict future cardiometabolic disorders with high accuracy. We will depict how we can combine medical imaging data with data from electronic medical records to improve the accuracy of such models. Overall, opportunistic imaging has the potential to be a paradigm-changing new tool to improve health outcomes through early detection and intervention without requiring additional diagnostic testing since it uses CT imaging that has already been acquired.

About Akshay Chaudhari
Dr. Chaudhari is an Assistant Professor in the Department of Radiology and (by courtesy) in the Department of Biomedical Data Science. He leads the Machine Intelligence in Medical Imaging research group at Stanford and has a primary research interest that lies at the intersection of artificial intelligence and medical imaging. Dr. Chaudhari is interested in the application of artificial intelligence techniques to all aspects of medical imaging, including automated schedule and reading prioritization, image reconstruction, quantitative analysis, and prediction of patient outcomes. His interests range from developing novel data-efficient machine learning algorithms to clinical deployment and validation of patient outcomes, both for medical imaging acquisition and subsequent analysis. He also conducts research in combining imaging with clinical, natural language, and time series data.

 

Hosted by: Garry Gold, MD
Sponsored by: PHIND Center & the Department of Radiology

Aug
17
Wed
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
Aug 17 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

Aug
18
Thu
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
Aug 18 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

Aug
19
Fri
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
Aug 19 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

Aug
20
Sat
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
Aug 20 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.

Aug
21
Sun
Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians (RECORDING) @ Online
Aug 21 all-day

Internet Enduring Material sponsored and presented by the Center for Continuing Medical Education at the Stanford School of Medicine. This is a recorded presentation of the Prostate Cancer CME Series: Treatment Across the Prostate Cancer Continuum for Primary Care Clinicians held on Monday, March 21, 2022 The goal of the series is to enhance understanding of increasingly complex treatment options and close knowledge gaps in earlier stages of prostate cancer. This session was targeted towards the primary care clinicians and included a discussion on the historical landscape of testing, blood based diagnostic biomarkers and screening, the latest in diagnostics, role of genetics and genomics and highlight existing disparities in prostate cancer.

Registration

Release Date: April 8, 2022
Expiration Date: April 7, 2023
Estimated Time to Complete: 2.0 hours
Registration Fee: FREE
*Originally recorded on March 27, 2022 

Credits

AMA PRA Category 1 Credits™ (2.00 hours), Non-Physician Participation Credit (2.00 hours), ANCC Contact Hours (2.00 hours), ACPE Contact Hours (2.00 hours)

Target Audience

Specialties – Family Medicine & Community Health, Hospital Medicine, Focused Practice, Internal Medicine, Medical Oncology

Professions – Advance Practice Nurse (APN), Nurse, Pharmacist (Pharm D)(BSPharm), Physician, Professional Nurse (RN)

Objectives

At the conclusion of this activity, learners should be able to:

  • Identify the different prostate cancer disease states in the castration-sensitive prostate cancer (CSPC) setting.
  • Navigate the lack of consensus in how to care for patients with prostate cancer in early stages of disease.
  • Explain the historical landscape of testing and screening in prostate cancer.
  • Describe the implications of health disparities in prostate cancer screening and treatment.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA) 

Stanford Medicine designates this Enduring Material for a maximum of 2.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 2 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN: JA0000751-0000-22-005-H01-P

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this internet enduring activity for a maximum of 2.0 ANCC contact hours.

For Pharmacists to Claim ACPE Credit
If you wish to apply for ACPE credit, please enter your NABP ePID# and Date of Birth in your CE Profile.
Go to Stanford’s CME portal > My CE > Profile tile > Credentials > Select NABP ePID# from the drop down and enter your ID number.
Please also enter your Date of Birth (month and day) in your profile under Basic Information.  The field will appear when you select your Profession as Pharmacist.